Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the performance of 312 definitions that used core set measures from either the International Myositis Assessment and Clinical Studies Group (IMACS) or the Paediatric Rheumatology International Trials Organisation (PRINTO) and were derived from natural history data and a conjoint analysis survey. They were further validated using data from the PRINTO trial of prednisone alone compared to prednisone with methotrexate or cyclosporine and the Rituximab in Myositis (RIM) trial. At a consensus conference, experts considered 14 top candidate criteria based on their performance characteristics and clinical face validity, using nominal group technique. Re...
Objective: The objective was to describe the methodology used to develop new response criteria for a...
Objective. The objective was to describe the methodology used to develop new response criteria for a...
OBJECTIVE: To validate a core set of outcome measures for the evaluation of response to treatment in...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
Objective. To develop response criteria for juvenile dermatomyositis (DM). Methods. We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
OBJECTIVE: To develop response criteria for juvenile dermatomyositis (DM). METHODS: We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
Objective: To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Method...
Objective: The objective was to describe the methodology used to develop new response criteria for a...
Objective: The objective was to describe the methodology used to develop new response criteria for a...
Objective. The objective was to describe the methodology used to develop new response criteria for a...
OBJECTIVE: To validate a core set of outcome measures for the evaluation of response to treatment in...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
Objective: To develop response criteria for juvenile dermatomyositis (DM). Methods: We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
Objective. To develop response criteria for juvenile dermatomyositis (DM). Methods. We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
OBJECTIVE: To develop response criteria for juvenile dermatomyositis (DM). METHODS: We analyzed the ...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
To develop response criteria for juvenile dermatomyositis (DM). We analysed the performance of 312 d...
Objective: To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM). Method...
Objective: The objective was to describe the methodology used to develop new response criteria for a...
Objective: The objective was to describe the methodology used to develop new response criteria for a...
Objective. The objective was to describe the methodology used to develop new response criteria for a...
OBJECTIVE: To validate a core set of outcome measures for the evaluation of response to treatment in...